AstraZeneca plc Beefs Up Precision Medicine Arsenal
AstraZeneca upped the ante in precision medicine with the announcement of four new collaborations.
Why Isis Pharmaceuticals, Inc. Shares Exploded Higher By 11% in January
Isis Pharmaceuticals' stock rockets higher in January following a bevy of positive press releases. Find out whether this phenomenal run in Isis can continue or if it'll soon fizzle out.